Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Endothelin-1 enhances the expression of the androgen receptor via activation of the c-myc pathway in prostate cancer cells.

Lee JG, Zheng R, McCafferty-Cepero JM, Burnstein KL, Nanus DM, Shen R.

Mol Carcinog. 2009 Feb;48(2):141-9. doi: 10.1002/mc.20462.

2.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

3.

Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.

Gong J, Zhu J, Goodman OB Jr, Pestell RG, Schlegel PN, Nanus DM, Shen R.

Oncogene. 2006 Mar 30;25(14):2011-21.

PMID:
16434977
4.

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.

Chen M, Feuerstein MA, Levina E, Baghel PS, Carkner RD, Tanner MJ, Shtutman M, Vacherot F, Terry S, de la Taille A, Buttyan R.

Mol Cancer. 2010 Apr 26;9:89. doi: 10.1186/1476-4598-9-89.

5.

Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).

Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J.

Prostate. 2007 Feb 1;67(2):178-89.

PMID:
17044040
6.

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T.

Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6.

7.

Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.

Ha S, Iqbal NJ, Mita P, Ruoff R, Gerald WL, Lepor H, Taneja SS, Lee P, Melamed J, Garabedian MJ, Logan SK.

Oncogene. 2013 Aug 22;32(34):3992-4000. doi: 10.1038/onc.2012.412. Epub 2012 Sep 17.

9.

Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.

Godoy-Tundidor S, Hobisch A, Pfeil K, Bartsch G, Culig Z.

Clin Cancer Res. 2002 Jul;8(7):2356-61.

10.

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.

Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9.

11.

A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.

Cherian MT, Wilson EM, Shapiro DJ.

J Biol Chem. 2012 Jul 6;287(28):23368-80. doi: 10.1074/jbc.M112.344671. Epub 2012 May 15.

12.

p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.

Clark EL, Hadjimichael C, Temperley R, Barnard A, Fuller-Pace FV, Robson CN.

PLoS One. 2013;8(1):e54150. doi: 10.1371/journal.pone.0054150. Epub 2013 Jan 17.

13.

GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.

Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW.

Prostate. 2007 Apr 1;67(5):521-35.

PMID:
17252539
14.

c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.

Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L.

Oncogene. 2006 Nov 16;25(54):7212-23. Epub 2006 May 29.

PMID:
16732317
15.
16.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
17.

The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells.

Zhang Y, Wang XW, Jelovac D, Nakanishi T, Yu MH, Akinmade D, Goloubeva O, Ross DD, Brodie A, Hamburger AW.

Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9890-5. Epub 2005 Jun 30.

18.
19.

Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2.

Cai C, Portnoy DC, Wang H, Jiang X, Chen S, Balk SP.

Cancer Res. 2009 Jun 15;69(12):5202-9. doi: 10.1158/0008-5472.CAN-09-0026. Epub 2009 Jun 2.

20.

A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.

Hessenkemper W, Roediger J, Bartsch S, Houtsmuller AB, van Royen ME, Petersen I, Grimm MO, Baniahmad A.

Mol Endocrinol. 2014 Nov;28(11):1831-40. doi: 10.1210/me.2014-1170. Epub 2014 Sep 9.

PMID:
25203674
Items per page

Supplemental Content

Write to the Help Desk